National Bank downgrades Nutrien stock rating on valuation

Nutrien was downgraded by National Bank Financial to Sector Perform from Outperform despite a strong run (up ~14% since the July 12 initiation) and the raised price target to $77 from $74. Valuation multiples have largely re-rated to peer levels (Nutrien ~7.0x 2027E EBITDA vs ~6.1x at initiation; FCF yield ~7% vs 9% prior), with an average 2026–2027 FCF yield now lower. Separately, the article notes mixed Q2 results (revenue $10.81B vs $10.70B expected; adj. EPS $2.61 vs $2.89 expected) and higher buybacks (~CAD 75M/month), contributing to a cautious near-term setup.

Analysis

The main market implication is that Nutrien has shifted from a simple valuation catch-up story to a self-funded capital-return story. Once a name is trading near its peer multiple, further upside depends on revisions, not just sentiment; that makes the stock more vulnerable to any slip in potash volumes, farm-gate pricing, or buyback disappointment over the next 1-3 months.

Second-order, a stalled rerating in NTR could redirect relative-value flows inside the ag complex toward higher-torque names like CF or MOS if investors want commodity beta, while ag-retail exposure could screen better than the stock if input demand stays stable. The broader fertilizer group still has a bid because cash flows are real, but the easy multiple expansion phase looks largely done unless the market gets a fresh catalyst from crop prices or tighter supply.

The contrarian piece is that the consensus may be underappreciating the downside cushion from repurchases and free cash flow yield. That argues against an aggressive short here; however, it also argues against chasing strength after a sharp run, especially with overbought technicals and no earnings revision to justify the move. Over 6-18 months, the key falsifier is whether mid-cycle EBITDA and volume assumptions hold—if not, the current peer-average multiple is likely too generous.

Key Decisions for Investors

• Do not add to NTR into strength; use any further rally toward the upper end of its recent valuation band as an opportunity to trim, with a 1-3 month thesis that multiple expansion has already been harvested.
• Relative-value trade: long CF or MOS vs short NTR for investors wanting fertilizer exposure with more operating torque; this works if the market starts rewarding earnings sensitivity over cash-return yield over the next 1-2 quarters.
• If holding NTR, hedge into the next earnings/guidance window with a modest put spread; the risk is a de-rating if potash volume guidance or capital return cadence disappoints.
• Set a watch alert for a pullback to sub-7x forward EV/EBITDA on NTR; that would be the point where the name regains asymmetric upside if buybacks and cash flow remain intact.